SFSG
ABBV icon

Stearns Financial Services Group’s AbbVie ABBV Stock Holding History

Stearns Financial Services Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$866K Sell
9,881
-507
-5% -$47.7K 0.14% 70
2020
Q2 		$1.02M Sell
10,388
-610
-6% -$53.7K 0.16% 56
2020
Q1 		$838K Sell
10,998
-217
-2% -$18.5K 0.15% 56
2019
Q4 		$993K Buy
11,215
+479
+4% +$39.8K 0.16% 60
2019
Q3 		$813K Sell
10,736
-1,227
-10% -$84.1K 0.14% 65
2019
Q2 		$870K Sell
11,963
-1,168
-9% -$91.8K 0.16% 62
2019
Q1 		$1.06M Sell
13,131
-1,983
-13% -$162K 0.2% 57
2018
Q4 		$1.39M Buy
15,114
+30
+0.2% +$2.64K 0.29% 44
2018
Q3 		$1.43M Buy
15,084
+114
+0.8% +$10.8K 0.32% 42
2018
Q2 		$1.39M Sell
14,970
-511
-3% -$49.9K 0.35% 38
2018
Q1 		$1.47M Sell
15,481
-972
-6% -$107K 0.36% 36
2017
Q4 		$1.59M Sell
16,453
-1,393
-8% -$131K 0.38% 35
2017
Q3 		$1.59M Sell
17,846
-2,808
-14% -$214K 0.4% 36
2017
Q2 		$1.5M Buy
20,654
+28
+0.1% +$1.88K 0.36% 43
2017
Q1 		$1.34M Sell
20,626
-7,297
-26% -$459K 0.33% 46
2016
Q4 		$1.75M Buy
27,923
+3,169
+13% +$193K 0.45% 37
2016
Q3 		$1.56M Buy
24,754
+1,662
+7% +$108K 0.42% 38
2016
Q2 		$1.43M Buy
23,092
+2,051
+10% +$125K 0.41% 38
2016
Q1 		$1.2M Buy
21,041
+1,182
+6% +$65.9K 0.36% 44
2015
Q4 		$1.18M Buy
19,859
+247
+1% +$14.2K 0.35% 47
2015
Q3 		$1.07M Buy
19,612
+216
+1% +$14.1K 0.35% 47
2015
Q2 		$1.3M Sell
19,396
-60
-0.3% -$3.92K 0.39% 42
2015
Q1 		$1.14M Buy
19,456
+490
+3% +$29.6K 0.35% 48
2014
Q4 		$1.24M Sell
18,966
-1,509
-7% -$95.1K 0.4% 40
2014
Q3 		$1.18M Sell
20,475
-4,894
-19% -$272K 0.42% 40
2014
Q2 		$1.43M Sell
25,369
-925
-4% -$48.5K 0.52% 36
2014
Q1 		$1.35M Sell
26,294
-907
-3% -$45.8K 0.52% 36
2013
Q4 		$1.44M Sell
27,201
-540
-2% -$26.5K 0.56% 36
2013
Q3 		$1.24M Sell
27,741
-1,010
-4% -$44.8K 0.54% 38
2013
Q2 		$1.19M Buy
+28,751
New +$1.26M 0.53% 38

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Stearns Financial Services Group's ABBV Position: Q3 2020 in Review

Stearns Financial Services Group reduced its AbbVie (ABBV) stake by 4.9% in Q3 2020, selling an estimated $47.7K and leaving 9,881 shares worth $866K. The position accounts for 0.14% of the portfolio, ranked #70.

Stearns Financial Services Group first reported a position in ABBV in Q2 2013 and has held it in 30 quarters since. The position peaked at $1.75M in Q4 2016. 2,366 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

  • Stearns Financial Services Group held 9,881 shares of AbbVie worth $866K as of Q3 2020.
  • Stearns Financial Services Group sold 507 AbbVie shares in Q3 2020, an estimated $47.7K.
  • AbbVie made up 0.14% of Stearns Financial Services Group's portfolio in Q3 2020, its #70 holding.
  • Stearns Financial Services Group first reported a position in AbbVie in Q2 2013 and has held it in 30 quarters since.
  • Stearns Financial Services Group's AbbVie position peaked at $1.75M in Q4 2016.
  • 2,366 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on Stearns Financial Services Group's 13F filing for Q3 2020, filed 30 Oct 2020.